Cisplatin-based neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) or chemoradiotherapy (CRT) is the standard of care for patients with muscle invasive bladder cancer (MIBC). Mutations ...

Excess body weight—including overweight and obesity—is a significant risk factor for cancer. Research from the American Cancer Society estimates that it contributes to approximately 5 percent of ...

American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA between February 13 th and 15 th 2025, was host to the Case-Based Session: Management of ...

The connection between obesity and thyroid cancer underscores the importance of maintaining a healthy weight. With scientific ...

In some cases, doctors may use the test to diagnose thyroid cancer, or other damage to the ... but they carry a small risk of complications. A person may feel slight pain or discomfort when ...

Problems with your menstrual cycle may be due to an underactive or overactive thyroid. How symptoms present could depend ... or hyperthyroidism who are pregnant have an increased risk of miscarrying.

Cancer patients with high muscle strength and cardiorespiratory fitness levels have significantly lower risk for all-cause mortality. HealthDay News — For patients diagnosed with cancer, high muscle ...

Exposure to high-normal, compared with low-normal, TSH levels was not associated with an elevated risk for differentiated thyroid cancer recurrence after thyroidectomy. Exposure to high-normal ...

Aspirin reduced colorectal cancer recurrence risk by 50% in patients with PIK3CA mutations over three years. Mutations in the PI3K pathway predict aspirin response, broadening its use to more patients ...

Aspirin reduced the risk of colorectal cancer recurrence by more than 50% in patients with PI3K-mutated disease who took a low dose once a day for 3 years, according to newly released data from the ...

“Aspirin has been shown to effectively reduce recurrence rates and improve disease-free survival,” said Anna Martling, MD, PhD. In patients with PIK3CA alterations in exon 9 and/or 20, the ...